Diligence memo · auto-generated · as of July 2, 2026

MIVI Neuroscience, Inc.

MIVI Neuroscience, Inc. looks under-valued against its niche peers and is quiet on financing cadence.

SourceModeled below same-niche peers while still financing on rhythm — a potential mispricing worth a closer look.

Businessfiled

MIVI Neuroscience, Inc. operates in Other Health Care, based in EDEN PRAIRIE.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

MIVI Neuroscience, Inc. has raised $67M in disclosed capital across 9 recorded rounds, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).

Largest single filing: $45M on 2020-12-18.

Most recent recorded round closed around 2024-05-15.

Valuation (modeled)modeled

Provath models MIVI Neuroscience, Inc. at approximately $4.3M (range $1.9M–$6.7M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Under-valued. Modeled value is 0.01× the median modeled value of Series C Other Health Care companies in 2022–2024 (47 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 11 months.

Last raise 2.1 yr ago; this sector typically re-raises about every 14 months.

Slightly overdue versus sector cadence.

The last round was 18.8× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 94% of Other Health Care peers (5377 compared).

Modeled value ranks above 18% of those peers.

Closest niche peers: Gravie, Inc., EmpowerMe Holdings, LLC, Color Holdings, L.P., RSR Senior Residences, LLC, Gynesonics, Inc.

Peoplefiled

19 named people on file across officers, directors and signatories.

Risks & flagsmixed

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.